Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours ; volume:63 ; number:8 ; day:10 ; month:8 ; year:2024 ; pages:1191-1204 ; date:8.2024
Clinical pharmacokinetics ; 63, Heft 8 (10.8.2024), 1191-1204, 8.2024
- Creator
-
Fernandez-Teruel, Carlos
Cullberg, Marie
Eberlein, Cath
Barry, Simon T.
Zhou, Diansong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-024-01407-x
- URN
-
urn:nbn:de:101:1-2411120921368.895557580229
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fernandez-Teruel, Carlos
- Cullberg, Marie
- Eberlein, Cath
- Barry, Simon T.
- Zhou, Diansong
- SpringerLink (Online service)
Other Objects (12)
Pan-cancer whole-genome analyses of metastatic solid tumours
Metastatic Tumours in Ovaries
Leptomeningeal metastases from solid tumours
Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study
Pharmacokinetics and excretion of 14C-omacetaxine in patients with advanced solid tumors
S79. CAR strategies in solid tumours
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
Pan-cancer whole-genome analyses of metastatic solid tumours
Metastatic Tumours in Ovaries
Leptomeningeal metastases from solid tumours
Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study
Pharmacokinetics and excretion of 14C-omacetaxine in patients with advanced solid tumors
S79. CAR strategies in solid tumours
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
Pan-cancer whole-genome analyses of metastatic solid tumours
Metastatic Tumours in Ovaries
Leptomeningeal metastases from solid tumours
Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study
Pharmacokinetics and excretion of 14C-omacetaxine in patients with advanced solid tumors
S79. CAR strategies in solid tumours
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours